<?xml version="1.0" encoding="UTF-8"?>
<p>Although it is too early to accept or reject the hypothesis and clinical relevance of ADE in SARS‐CoV‐2, actual research in clinical diagnosis and vaccine and therapy development needs to consider such possibility. Even after nearly 20 years of vaccine research for SARS‐CoV and 10 years for MERS‐CoV, there are still not any approved vaccines and antiviral treatments available (
 <xref rid="cytoa24047-bib-0051" ref-type="ref">51</xref>), particularly due to severe complications encountered during animal testing (
 <xref rid="cytoa24047-bib-0024" ref-type="ref">24</xref>).
</p>
